Heart failure clue: blood gas may predict CRT success

NCT ID NCT07436377

First seen Feb 28, 2026 · Last updated Jun 23, 2026 · Updated 18 times

Summary

This study looks at 65 heart failure patients getting a cardiac resynchronization therapy (CRT) device. Researchers will take a blood sample from a vein near the heart during the procedure to measure blood gas levels. The goal is to see if these levels can help predict which patients will have better outcomes, like fewer hospital visits or improved heart function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Trakya University Faculty of Medicine Hospital

    Edirne, 22100, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors identify which heart failure patients will benefit most from a cardiac resynchronization therapy (CRT) device before implantation.

What could go wrong

This is a small, observational study (65 people) that only looks for a link, not a treatment. The findings may not apply to all heart failure patients or change current practice.

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.